Monitoring therapeutic efficacy by real-time detection of Mycobacterium tuberculosis mRNA in sputum

Clinical Chemistry

Volumn 55, Issue 9, 2009, Pages 1694-1700

  Mdivani, Nino ^a   Li, Haijing ^b   Akhalaia, Maka ^c   Gegia, Medea ^a   Goginashvili, Leila ^c   Kernodle, Douglas S ^b   Khechinashvili, George ^a   Tang, Yi Wei ^b,d  

^a Georgian Foundation Against Tuberculosis and Lung Diseases   (Georgia)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c National Center of Tuberculosis and Lung Diseases   (Georgia)

^d VANDERBILT UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; MESSENGER RNA; NUCLEIC ACID; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; CONTROLLED STUDY; DNA PROBE; DRUG EFFICACY; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; GENE INSERTION SEQUENCE; GROWTH RATE; HUMAN; HYDROLYSIS; INTERMETHOD COMPARISON; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MONITORING; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SPUTUM ANALYSIS; SPUTUM CULTURE; STAINING; TREATMENT RESPONSE; ZIEHL NEELSEN STAINING;

ADULT; ANTITUBERCULAR AGENTS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MALE; MYCOBACTERIUM TUBERCULOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, BACTERIAL; RNA, MESSENGER; SPUTUM; TIME FACTORS; TUBERCULOSIS, PULMONARY;

MYCOBACTERIUM TUBERCULOSIS;

EID: 69549083329     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2009.124396     Document Type: Article

References (38)

1. Mitchison DA. Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months. Am Rev Resp Dis 1993;147:1062-1063
2. Jindani A, Aber VR, Edwards EA, Mitchison DA. The early bactericidal activity of drugs in patients with pulmonary tuberculosis. Am Rev Resp Dis 1980;121:939-949 (Pubitemid 10118376)
3. Brisson-Noel A, Gicquel B, Lecossier D, Levy-Frebault V, Nassif X, Hance AJ. Rapid diagnosis of tuberculosis by amplification of mycobacterial DNA in clinical samples. Lancet 1989;2:1069-1071 (Pubitemid 19264077)
4. Kaul KL. Molecular detection of Mycobacterium tuberculosis: impact on patient care. Clin Chem 2001;47:1553-1558
5. Tang YW, Meng S, Li H, Stratton CW, Koyamatsu T, Zheng X. PCR enhances acid-fast bacillus stain-based rapid detection of Mycobacterium tuberculosis. J Clin Microbiol 2004;42:1849-1850 (Pubitemid 38500859)
6. Thwaites GE, Caws M, Chau TT, Dung NT, Campbell JI, Phu NH, et al. Comparison of conventional bacteriology with nucleic acid amplification (amplified mycobacterium direct test) for diagnosis of tuberculous meningitis before and after inception of antituberculosis chemotherapy. J Clin Microbiol 2004;42:996-1002. (Pubitemid 38332816)
7. Shankar P, Manjunath N, Mohan KK, Prasad K, Behari M, Shriniwas, Ahuja GK. Rapid diagnosis of tuberculous meningitis by polymerase chain reaction. Lancet 1991;337:5-7.
8. Drosten C, Panning M, Kramme S. Detection of Mycobacterium tuberculosis by real-time PCR using pan-mycobacterial primers and a pair of fluorescence resonance energy transfer probes specific for the M. tuberculosis complex. Clin Chem 2003;49:1659-1661 (Pubitemid 37194221)
9. Walker GT, Nadeau JG, Linn CP, Devlin RF, Dandliker WB. Strand displacement amplification (SDA) and transient-state fluorescence polarization detection of Mycobacterium tuberculosis DNA. Clin Chem 1996;42:9-13. (Pubitemid 26030375)
10. Tang YW, Procop GW, Persing DH. Molecular diagnostics of infectious diseases. Clin Chem 1997;43:2021-2038
11. Fenhalls G, Stevens L, Moses L, Bezuidenhout J, Betts JC, van Helden P, et al. In situ detection of Mycobacterium tuberculosis transcripts in human lung granulomas reveals differential gene expression in necrotic lesions. Infect Immun 2002;70:6330-6338
12. Aellen S, Que YA, Guignard B, Haenni M, Moreillon P. Detection of live and antibiotic-killed bacteria by quantitative real-time PCR of specific fragments of rRNA. Antimicrob Agents Chemother 2006;50:1913-1920 (Pubitemid 43807505)
13. Desjardin LE, Perkins MD, Wolski K, Haun S, Teixeira L, Chen Y, et al. Measurement of sputum Mycobacterium tuberculosis messenger RNA as a surrogate for response to chemotherapy. Am J Resp Crit Care Med 1999;160:203-210 (Pubitemid 29326089)
14. Jou NT, Yoshimori RB, Mason GR, Louie JS, Liebling MR. Single-tube, nested, reverse transcriptase PCR for detection of viable Mycobacterium tuberculosis. J Clin Microbiol 1997;35:1161-1165
15. Eltringham IJ, Drobniewski FA, Mangan JA, Butcher PD, Wilson SM. Evaluation of reverse transcription-PCR and a bacteriophage-based assay for rapid phenotypic detection of rifampin resistance in clinical isolates of Mycobacterium tuberculosis. J Clin Microbiol 1999;37:3524-3527
16. Hu Y, Mangan JA, Dhillon J, Sole KM, Mitchison DA, Butcher PD, Coates AR. Detection of mRNA transcripts and active transcription in persistent Mycobacterium tuberculosis induced by exposure to rifampin or pyrazinamide. J Bacteriol 2000;182:6358-6365 (Pubitemid 30812404)
17. World Health Organization (WHO). Global tuberculosis control: surveillance, planning, financing: WHO report 2008. Geneva: WHO; 2008. Publication WHO/HTM/TB/2008.393.
18. Mdivani N, Zangaladze E, Volkova N, Kourbatova E, Jibuti T, Shubladze N, et al. High prevalence of multidrug-resistant tuberculosis in Georgia. Int J Infect Dis 2008;12:635-644
19. Weinstock DM, Hahn O, Wittkamp M, Sepkowitz KA, Khechinashvili G, Blumberg HM. Risk for tuberculosis infection among internally displaced persons in the Republic of Georgia. Int J Tuberc Lung Dis 2001;5:164-169 (Pubitemid 32401861)
20. Gegia M, Mdivani N, Mendes RE, Li H, Akhalaia M, Han J, et al. Prevalence of and molecular basis for tuberculosis drug resistance in the Republic of Georgia: validation of a QIAplex system for detection of drug resistance-related mutations. Antimicrob Agents Chemother 2008;52:725-729 (Pubitemid 351170851)
21. World Health Organization (WHO). Treatment of tuberculosis: guidelines for national programmes. 3rd ed. Geneva: WHO; 2003. Publication WHO/ CDS/TB/2003.313.
22. Li H, Dummer JS, Estes WR, Meng S, Wright PF, Tang YW. Measurement of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipients. J Clin Microbiol 2003;41:187-191 (Pubitemid 36098574)
23. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009;55:611-622
24. Mokrousov I, Otten T, Vyshnevskiy B, Narvskaya O. Detection of embB306 mutations in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis from northwestern Russia: implications for genotypic resistance testing. J Clin Microbiol 2002;40:3810-3813
25. Tang YW, Sefers SE, Li H, Kohn DJ, Procop GW. Comparative evaluation of three commercial systems for nucleic acid extraction from urine specimens. J Clin Microbiol 2005;43:4830-4833 (Pubitemid 41298287)
26. Cave MD, Eisenach KD, McDermott PF, Bates JH, Crawford JT. IS6110: conservation of sequence in the Mycobacterium tuberculosis complex and its utilization in DNA fingerprinting. Mol Cell Probes 1991;5:73-80.
27. Desjardin LE, Chen Y, Perkins MD, Teixeira L, Cave MD, Eisenach KD. Comparison of the ABI 7700 system (TaqMan) and competitive PCR for quantification of IS6110 DNA in sputum during treatment of tuberculosis. J Clin Microbiol 1998;36:1964-1968.
28. De Wit L, de la Cuvellerie A, Ooms J, Content J. Nucleotide sequence of the 32 kDa-protein gene (antigen 85 A) of Mycobacterium bovis BCG. Nucleic Acids Res 1990;18:3995. (Pubitemid 20222946)
29. Li H, McCormac MA, Estes RW, Sefers SE, Dare RK, Chappell JD, et al. Simultaneous detection and high-throughput identification of a panel of RNA viruses causing respiratory tract infections. J Clin Microbiol 2007;45:2105-2109 (Pubitemid 47203777)
30. Dye C. Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis. Nat Rev Microbiol 2009;7:81-87
31. Desjardin LE, Perkins MD, Teixeira L, Cave MD, Eisenach KD. Alkaline decontamination of sputum specimens adversely affects stability of mycobacterial mRNA. J Clin Microbiol 1996;34:2435-2439 (Pubitemid 26307787)
32. Honore-Bouakline S, Vincensini JP, Giacuzzo V, Lagrange PH, Herrmann JL. Rapid diagnosis of extrapulmonary tuberculosis by PCR: impact of sample preparation and DNA extraction. J Clin Microbiol 2003;41:2323-2329 (Pubitemid 36712431)
33. Mistry R, Cliff JM, Clayton CL, Beyers N, Mohamed YS, Wilson PA, et al. Gene-expression patterns in whole blood identify subjects at risk for recurrent tuberculosis. J Infect Dis 2007;195:357-365 (Pubitemid 46146113)
34. Siawaya JF, Bapela NB, Ronacher K, Beyers N, van Helden P, Walzl G. Differential expression of interleukin-4 (IL-4) and IL-4δ2 mRNA, but not transforming growth factor beta (TGF-β), TGF-βRII, Foxp3, gamma interferon, T-bet, or GATA-3 mRNA, in patients with fast and slow responses to antituberculosis treatment. Clin Vaccine Immunol 2008;15:1165-1170
35. Ribeiro-Rodrigues R, Resende Co T, Johnson JL, Ribeiro F, Palaci M, Sá RT, et al. Sputum cytokine levels in patients with pulmonary tuberculosis as early markers of mycobacterial clearance. Clin Diagn Lab Immunol 2002;9:818-823 (Pubitemid 34773884)
36. Dietze R, Teixeira L, Rocha LM, Palaci M, Johnson JL, Wells C, et al. Safety and bactericidal activity of rifalazil in patients with pulmonary tuberculosis. Antimicrob Agents Chemother 2001;45:1972-1976 (Pubitemid 32591685)
37. O'Brien RJ. Studies of the early bactericidal activity of new drugs for tuberculosis: a help or a hindrance to antituberculosis drug development? Am J Respir Crit Care Med 2002;166:3-4.
38. Sirgel FA, Donald PR, Odhiambo J, Githui W, Umapathy KC, Paramasivan CN, et al. A multicentre study of the early bactericidal activity of anti-tuberculosis drugs. J Antimicrob Chemother 2000;45:859-870 (Pubitemid 30348958)